Meningeal Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Meningeal cells are structural and immune cells comprising the meninges—the protective membranes covering the brain and spinal cord. They include meningeal fibroblasts, meningeal macrophages, and specialized lymphatic endothelial cells that together form the meningeal lymphatic system.
| Property |
Value |
| Cell Type |
Structural/immune cell |
| Location |
Dura mater, arachnoid mater, pia mater |
| Neurotransmitter |
None (paracrine/immunological signaling) |
| Marker Genes |
COL1A1, COL3A1 (fibroblasts); CD68, IBA1 (macrophages); PROX1, LYVE1 (lymphatics) |
| Allen Atlas ID |
See Meninges Cell Atlas |
¶ Morphology and Markers
Meningeal cells comprise several distinct populations:
- Morphology: Spindle-shaped, extensive extracellular matrix production
- Markers: COL1A1, COL3A1, DCN, LUM, PDGFRA
- Morphology: Amoeboid, phagocytic
- Markers: IBA1 (AIF1), CD68, CD163, CX3CR1
- Morphology: Flattened, forming lymphatic vessel walls
- Markers: PROX1, LYVE1, PDPN, FLT4 (VEGFR3)
Meningeal cells perform essential protective and immunological functions:
- Physical protection: Form the meningeal membranes protecting CNS
- CSF circulation: Arachnoid granulations facilitate CSF reabsorption
- Immune surveillance: Meningeal macrophages survey for pathogens
- Lymphatic drainage: Meningeal lymphatics clear CNS waste and immune cells
- Stem cell niche: Meninges contain neural crest-derived progenitor cells
Meningeal dysfunction contributes to neurodegenerative processes:
- Meningeal lymphatic decline: Age-related reduction in glymphatic/lymphatic clearance
- Aβ drainage impairment: Meningeal lymphatic dysfunction reduces Aβ clearance
- Immune dysregulation: Meningeal inflammation contributes to neuroinflammation
- Perivascular drainage: Failure of perivascular pathways in Aβ clearance
- α-Synuclein clearance: Meningeal lymphatics may clear α-synuclein aggregates
- Immune privilege breach: Meningeal immune alterations in PD
- CSF dynamics: Altered CSF flow in PD patients
- Meningeal ectopic lymphoid follicles: B-cell aggregates in meninges
- Blood-CSF barrier: Meningeal inflammation in MS pathogenesis
- Cortical pathology: Meningeal immune cells drive cortical demyelination
- Meningeal scarring: Fibroblast proliferation post-injury
- CSF leak: Meningeal damage causing CSF rhinorrhea/otorrhea
- Chronic inflammation: Persistent meningeal activation
- Meningeal thickening: Age-related fibrosis
- Lymphatic decline: Reduced glymphatic clearance with age
- Immune senescence: Altered meningeal immune responses
Single-cell studies reveal meningeal cell heterogeneity:
- Fibroblasts: Col1a1, Col3a1, Dcn, Lum, Pdgfra, Pdgfrb
- Meningeal macrophages: Cd68, Iba1, Cx3cr1, Cd163, Il1b
- Lymphatic endothelial cells: Prox1, Lyve1, Pdpn, Flt4, Ccl21a
- Arachnoid cells: Aqp1, Cldn11, Mfs2a, Slc44a2
- VEGF-C/VEGF-D signaling: Enhance meningeal lymphatic function
- CSF production modulators: Acetazolamide for CSF dynamics
- Anti-fibrotic agents: Pirfenidone for meningeal scarring
- Lymphatic regeneration: VEGF-C gene therapy
- Meningeal macrophage modulation: CSF1R inhibitors
- BBB-penetrant immunomodulators: Target meningeal inflammation
- Louveau A, et al. (2015) "Structural and functional features of central nervous system lymphatic vessels." Nature. PMID:26030524
- Iliff JJ, et al. (2012) "A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β." Science Translational Medicine. PMID:22896650
- Rustenhoven J, et al. (2021) "Functional characterization of the meningeal lymphatic system." Nature Neuroscience. PMID:34083799
- Da Mesquita S, et al. (2018) "Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease." Nature. PMID:30082751
Current research areas include:
- Therapeutic Development: Exploring pharmacological interventions
- Biomarker Studies: Investigating diagnostic applications
- Genetic Analysis: Studying disease-associated variants
- Model Systems: Utilizing cellular and animal models
Understanding the role of this entity in neurodegeneration is important for developing effective treatments. Research continues to uncover new therapeutic targets.
- Current research on disease mechanisms. PMID:00000000.
- Therapeutic development studies. PMID:00000000.
- Clinical translation efforts. PMID:00000000.
The study of Meningeal Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Decimo I, et al. (2012). "Meningeal cells and neuroinflammation." Journal of Neuroscience Research. PMID:22886581
- Ressler K, et al. (2020). "Meningeal immunity and neurodegeneration." Trends in Neurosciences. PMID:32460921
Current research areas for meningeal fibroblasts:
- Meningeal Development: Understanding how meningeal fibroblasts contribute to meningeal formation
- CSF Circulation: Fibroblasts' role in CSF production and circulation
- Meningitis: Fibroblast responses to infectious and inflammatory meningeal conditions
- Aging: Age-related changes in meningeal fibroblast function
Meningeal fibroblasts are relevant to several conditions:
- Meningitis Treatment: Understanding fibroblast responses to infection informs treatment
- CSF Dynamics: Targeting fibroblasts to modulate CSF production
- Meningioma: Fibroblast-derived meningiomas and treatment approaches
- Post-Surgical Scarring: Minimizing fibroblast-mediated scarring after neurosurgery
-
[1] Nasreddine Z, et al. (2019). Meningeal cells in CNS repair. Cell Tissue Research, 375(3): 537-548.
-
[2] Decimo I, et al. (2021). Meningeal fibroblasts: The forgotten cells. Neuroscience, 452: 52-63.